Solitary cancer cells as a possible source of tumour dormancy?
about
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelDetyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment.The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthThe architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.Prospective identification of glioblastoma cells generating dormant tumors.Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates.Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and CancerWhat can be learnt about disease progression in breast cancer dormancy from relapse data?Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case reportApoptosis, autophagy, necroptosis, and cancer metastasisA dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cellsEpoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in miceDo we need to redefine a cancer metastasis and staging definitions?Tumour dormancy in breast cancer: an updateThe transcription factor SPDEF suppresses prostate tumor metastasisTumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells?Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancyBreast cancer metastasis progression as revealed by intravital videomicroscopy.Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.Models, mechanisms and clinical evidence for cancer dormancy.Tumour dormancy and clinical implications in breast cancer.The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities.Circulating tumor cells: detection, molecular profiling and future prospects.An evolutionary explanation for the perturbation of the dynamics of metastatic tumors induced by surgery and acute inflammation.Primary and metastatic tumor dormancy as a result of population heterogeneity.E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.Lessons from cancer immunoediting in cutaneous melanoma.Biomarkers and mechanisms associated with recurrent prostate cancer.Cancer-immune equilibrium: questions unansweredSMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy.The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer.Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment.
P2860
Q21090788-41DC0C69-E6AF-42FD-8B94-AF0DB7EB490FQ30502337-E76F4B0D-8D60-4522-8206-31B6292164B5Q33649574-FE685E6F-85C8-4C8E-989E-BB4F5F5495CFQ33798648-D91F7E4C-ADEA-4050-ADD4-89781455EE29Q34284428-5353F356-1407-4C61-9F2F-C6EEFA614E85Q34412360-6154C2E0-8A3B-41D0-A01D-3830DE8712F9Q34447304-7474C152-07F8-4DA3-AE6A-D8D73432CAB6Q34573041-EFABCD1D-0AB2-4314-B050-F733E6367B1FQ34576070-3266A007-0F15-4519-8E18-6BE559777E2CQ34720547-9EDC1C03-5335-43C1-A552-1B85ED98291BQ35042311-77E67FD7-E00C-4B2F-9688-4CE634FDDB49Q35128650-7D4BBBBE-2DDD-40B2-9A6C-5906C0366484Q35626062-C7B70D11-BEE0-47A3-BE39-5444F728856BQ35640579-649BE283-E964-4822-8522-7332DFB6B6F9Q35792651-3DEAFBBD-AAE4-49CB-AF6A-68D6A4BD995FQ35906302-643B4F72-4C91-43C0-BF9C-6C475BE0CAF6Q36215965-0C70A8BD-74DA-44BE-9EDC-7555FD575CEEQ36544420-529A0CCB-B89A-462E-8C2C-399F2358B4C0Q36575331-0E39E5F9-948A-452B-9FD4-9C13EE009933Q36613998-DA3D6C5B-8BE0-45CD-8057-D5A078BDE068Q36616513-55A32D9F-8258-4D58-89CE-534EA7146757Q36696272-623B6ABE-01A4-4F33-8625-0AB8D138FB9DQ36844303-7824556C-5DD8-4672-88A9-F388EF084057Q36863179-A4DE1CF1-116F-48A2-B064-0001D4D9A088Q36983954-CB0152F3-F5F8-41E7-A50C-2251E45F34ECQ37027492-D321A76A-8D1E-4F38-8891-8A468E7BBFE4Q37129834-D400C2E7-AEDD-4E1E-8D5F-2C6E7960BBD3Q37196014-029F6785-6BFC-4E83-900B-7AEA930B432CQ37531718-20259F40-7494-4CA6-AEE0-1FE8367F9AB3Q37605872-332E386B-76A7-403A-ABF9-6F7BBE40E2B7Q38038176-8DF27667-C825-47B4-8AB1-C077C3683F42Q38175727-E3B755C1-0A10-419B-ABDA-06265B240965Q38366247-C0698106-1882-45D7-84AC-49FEA0BEA837Q38906952-4F61D960-921C-41A8-9EB9-14758B27831CQ46919410-802C43F2-4220-4748-BC4D-5191E13E51FEQ47133357-8B28B534-8BD8-443D-8944-1B1DEBAA923C
P2860
Solitary cancer cells as a possible source of tumour dormancy?
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Solitary cancer cells as a possible source of tumour dormancy?
@ast
Solitary cancer cells as a possible source of tumour dormancy?
@en
Solitary cancer cells as a possible source of tumour dormancy?
@nl
type
label
Solitary cancer cells as a possible source of tumour dormancy?
@ast
Solitary cancer cells as a possible source of tumour dormancy?
@en
Solitary cancer cells as a possible source of tumour dormancy?
@nl
prefLabel
Solitary cancer cells as a possible source of tumour dormancy?
@ast
Solitary cancer cells as a possible source of tumour dormancy?
@en
Solitary cancer cells as a possible source of tumour dormancy?
@nl
P2093
P356
P1476
Solitary cancer cells as a possible source of tumour dormancy?
@en
P2093
Chambers AF
MacDonald IC
P304
P356
10.1006/SCBI.2001.0382
P577
2001-08-01T00:00:00Z